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Abstract
Effects of propranolol on ischemic segmental function were studied in anesthetized open-chest
dogs. Two segment-length gauges were used for measuring the regional myocardial function:
one was sutured on to the left ventricular surface perfused by the anterior descending coronary
artery (ischemic zone) and the other was on to that perfused by the circumflex coronary artery
(normal zone). A bolus of propranolol (0.5 mg/kg) was injected into the right femoral vein. Five
min later, the left anterior descending coronary artery (LAD) was completely occluded for one
mine and thereafter released. Then a second coronary occlusion for 20 min was performed; an
interval of 20 min was allowed between two occlusions. Propranolol, in the ischemic segment,
apparently decreased the extent of paradoxical lengthening in the late systole following one min
LAD occlusion, and facilitated improvement of segmental function after release of the occlusion.
Moreover, the extent of abnormal stretching induced by 20 min occlusion during early systole, was
also reduced by propranolol pretreatment. In contrast, compensatory increase in shortening by the
normal segment was disturbed by propranolol. These results suggest that propranolol might exert
a favourable influence on the segmental myocardial function during either transient or maintained
myocardial ischemia.
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Abstract. Effects of propranolol on ischemic segmental function
were studied in anesthetized open-chest dogs. Two segment-length
gauges were used for measuring the regional myocardial function: one
was sutured on to the left ventricular surface perfused by the anterior
descending coronary artery (ischemic zone) and the other was on to that
perfused by the circumflex coronary artery (normal zone). A bolus of
propranolol (0.5mgjkg) was injected into the right femoral vein. Five min
later, the left anterior descending coronary artery (LAD) was completely
occluded for one min and thereafter released. Then a second coronary
occlusion for 20 min was performed; an interval of 20 min was allowed
between two occlusions. Propranolol, in the ischemic segment, appar-
ently decreased the extent of paradoxical lengthening in the late systole
following one min LAD occlusion, and facilitated improvement of seg-
mental function after release of the occlusion. Moreover, the extent
of abnormal stretching induced by 20min occlusion during early systole,
was also reduced by propranolol pretreatment. In contrast, compen-
satory increase in shortening by the normal segment was disturbed by
propranolol. These results suggest that propranolol might exert a fa-
vourable influence on the segmental myocardial function during either
transient or maintained myocardial ischemia.
Key words: propranolol, regional myocardial function, ischemia
In the past few years much attention has been directed towards various
methods of therapeutic intervention which slow or prevent the development
of myocardial necrosis following an acute coronary artery occlusion (1, 2).
Propranolol has been suggested as a possible means of reducing acute ischemic
injury and thus potentially protecting myocardial tissue (3). An important
cause of impaired cardiac function in ischemic heart disease, however, is mechan-
ical dysfunction of different regions of the ventricle in addition to myocardial
tissue loss (4, 5). The effect of propranolol on regional contractile function of
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the ischemic and normal zones following coronary occlusion has not been evalu-
ated sufficiently. The purpose of this study therefore was to determine the effect
of propranolol on both ischemic and normal zonal contractile performance.
METHODS
Experiments were performed in 14 mongrel dogs weighing 10-20 kg under
anesthesia with intravenous sodium pentobarbital (25-30 mgjkg). Seven dogs were
used for propranolol pretreatment and the remainder for control. The animals
were respirated with rOom air through an endotracheal tube connected to an
intermittent positive pressure pump. A polyethylene tube was inserted into the
right femoral vein for intravenous injection. A stiff bore catheter (#8 French) was
introduced into the ascending aorta by way of the right femoral artery for monitor-
ing central aortic pressure. Pressure was measured with Nihonkoden model MP-
24T strain gauge placed at the midchest level. The heart was exposed through
a left thoracotomy in the fifth intercostal space and supported with a pericardial
cradle. The left anterior descending coronary artery (LAD) was isolated and a
loose ligature was placed around the vessel. The ends of the ligature were threaded
through a short plastic tube for occluding the vessel. An electromagnetic flow
transducer was positioned around the aorta as near its root as possible for mea-
suring aortic blood flow. Two strain gauges (Nihonkoden model RP-5) were used
for measuring the segment-length; one was placed with deep sutures on the left
ventricular wall perfused by the LAD (ischemic area), perpendicular to the inter-
ventricular septum, and the other was sutured on to the left ventricular surface
(supplied by the left circumflex coronary artery [normal area]) in parallel with
the gauge in the ischemic area (Fig. 1, left). A segment-length of approximately
1.0 cm of myocardium was delineated by the points of attachment of the gauge.
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Pressur.e
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Flow
Fig.!. Schematic illustration of instrumentation and the points analyzed in the
segment-length curve.
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After instrumentation was completed, seven dogs were given a bolus of 0.5
mg/kg of propranolol intravenously via the tube placed in the right femoral vein.
Five min after the injection of propranolol, the LAD was completely occluded
for one min and then released. Twenty min later a second occlusion of the LAD
was performed for 20 min.
As a control, the same procedures except for pretreatment with propranolol
were carried out on another seven dogs.
Hemodynamic variables and segment-length curves were recorded with a lead
II electrocardiogram using a multichannel direct visual oscillograph (Yokogawa-
Denki, model 2901) at paper speed of 100 mm per second.
Though strict attention was paid to applying the gauge in the same position
on each heart and to delineate the same myocardial length between the points of
attachment of the gauge, the actual attachment of the gauge was not completely
the same in individual animals. Therefore, the dimension of each point in the
segment-length curve was expressed as millimeters from point A prior to the
LAD occlusion.
The unpaired Student's t-test was used for comparison of the data between
the groups, and the paired Student's t-test was used for comparison within the
group.
RESULTS
The segment-length curve was named at four points and analyzed according
to Tawara (6) as illustrated in Fig. I (right). Point A and point B were coin-
cident with the end of diastole and early phase of left ventricular ejection, re-
spectively. Point C appeared at the phase of reducing ejection and point D syn-
chronized at the end of ejection.
TABLE l. HEMODYNAMIC DATA BEFORE OCCLUSION OF THE LAD
Heart rate LVET SV Systolic BP Diastolic BP
(beat/min) (sec.) (mll (mmHg) (mmHg)
A. Before the LAD occlusion for one minute.
Pretreated M 125 0.17 15.0 122a 90
with
propranolol SD 20.8 0.08 0.80 8.6 9.0
M 150 0.18 15.5 142 94
Control
SD 22.5 0.03 0.62 8.0 8. 7
B. Before the LAD occlusion for 20 minute.
Pretreated M 150 0.17 15.1 120a 89
with
propranolol SD 18.6 0.02 0.84 8.0 6.2
M 146 0.18 15.3 138 92
Control
SD 24.6 0.04 O. 73 6.5 8.6
LVET=left ventricular ejection time; SV = stroke volume; BP = blood pressure.
M=mean, SD=standard deviation of mean.
a Significant difference from control (P<O.Ol).
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Effects of propranolol (Table 1). Intravenous injection of propranolol signif-
icantly slowed the heart rate (P<O.O I) and decreased the systolic blood pressure
(P<O.O I). A significant difference from the control group, however, was only
seen in the systolic blood pressure prior to occlusion of the LAD.
In segment-length, point A was slightly but significantly (P<O.O I) streched
in association with a marginal decrease in the dimensions of points B, C and D.
Effects of LAD occlusion. One min occlusion of the LAD caused a slight
elongation of point A in the propranolol group the same as in the control group.
Paradoxical systolic lengthening in ischemic myocardial segment was produced
by LAD occlusion at points B, C and D. Points Band C in propranolol group
lengthened the same as those in control group. However, lesser reduction in the
dimension of point D occurred in the propranolol group at 10, 20 and 40 seconds
after the occlusion (P<0.05, P<0.05, P<O.OI, respectively) as represented in
Table 2 and Fig. 2.
TABLE 2. SEGMENT-LENGTH (MMI BEFORE, DURING AND AFTER ONE MIN
OCCLUSION OF THE LAD
Pretreated with propranolol Control
Point A Point B Point C Point D Point A Point B Point C Point D
Before M 0 -0.13 2.90 2.60 0 -0.20 3.21 2.56
occlusion SD 0.46 0.25 0.28 0.28 0.37 0.28
After the occlusion
10 sec M 0 -0.10 2.43 0,83
a
-0.20 -0.40 2.80 0.33
SD 0.08 0.29 0.52 0.41 O. 12 0.32 0.22 0.26
20 sec M -0.10 -0.50 1. 97 0.17
a
-0.26 -0.62 2.16 -0.41
SD 0.08 0.36 0.43 0.56 0.08 0.34 0.43 0.18
M -0.17 -1. 70 -0.20 -1. 57b -0.31 -1. 85 -0.38 -2.5840 sec SD 0.09 0.62 0.68 0.53 0.14 0.49 0.36 O. 16
After release of the occlusion
Release M -0.37 -2.86 -1. 50 -2.43 -0.63 -3.23 -1. 59 -2.81
(0 sec) SD O. 12 0.33 0.76 0.83 0.18 0.52 0.40 O. 18
10 sec M -0.20
-0. gob 1. 16b 1. lOb -0.62 -3.23 0.20 -0.61
SD 0.08 0.50 0.41 0.36 0.18 0.50 0.39 0.20
20 sec M -0.10 -0.87
c I. BOb 1. 63a -0.55 -1. 78 1. 02 1. 20
SD 0.08 0.53 0.24 0.21 0.20 0.41 0.38 0.21
M -0.10 -0.57 2.33a 2.03 -0.24 -0.63 2.56 2.0440 sec SD 0.08 0.36 0.20 0.24 O. 16 0.45 0.31 0.20
M -0.10 -0.03 2. 77 2.38 -0.20 -0.22 2.88 2. 2560 sec SD 0.08 0.50 0.36 0.37 O. 18 0.37 0.40 0.26
M=mean, SD = standard deviation.
Significant difference from the control, a P<0.05, b P<O.OOI, c P<O.01.
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Fig. 2. Dimensional changes in points of the segment-length curve in the ische-
mic zone during and after brief coronary occlusion.
Significant difference between the two groups: **P<O.OOl, *P<O.OI, +P<0.05.
Throughout this period, the segment-length in the normal area showed only
little change. A significant decrease in stroke volume (P<O.OOl), left ventric-
ular ejection time (P<O.OOl) and systolic blood pressure (P<O.Ol) was seen
during. one min of LAD occlusion in both canine groups. The percent decrease
in the propranolol group, however, was slightly less than the control group in
the lefrventricular ejection time (LVET) and systolic blood pressure, and signifi-
cantlyso in stroke volume (P<0.05) (Table 3).
Reflow in the LAD caused a more rapid improvement in stroke volume and
systolic blood pressure. Stroke volume in the propranolol group returned to the
preocclusion level within 10 sec and rather increased during the following
10 sec, while in the control group longer than 20 sec was required for restoration
(Fig. 3). The release of LAD occlusion improved abnormal contraction for a
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short time in points B, C and D. Recovery appeared more rapidly in the pro-
pranolol group than in the control; a significant difference in the dimension be-
tween groups was seen for points B, C and D at 10 and 20 sec following the release
of the coronary artery occlusion.
TABLE 3. PERCENT CHANGES OF HEMODYNAMIC MEASUREMENTS DURING
AND AFTER ONE MIN LAD OCCLUSION ('Yo)
Pretreated with propranolol Control
LVET SV sBP dBP LVET SV sBP dBP
Time after LAD occlusion.
10 sec M 88.0 88.6 95.2 94.5 84.5 85.8 96.4 87.6SD 3. 7 3.3 7.0 10.0 3. 7 5. 7 3.3 6.5
20 sec M 86.0 90.1" 95.3 96.4 84. 1 84.1 94.0 90.0SD 2.6 4. 1 5.9 9.2 6.2 5. 7 2.8 6.3
40 sec M 94.2 91. 2
a 91. 4 93. 7 89.5 83.2 91. 0 90.5
SD 6.2 5.3 6.2 7.6 8.9 6.5 3.8 6. 7
Time after release of the LAD occlusion.
Release M 97.4 94.0a 93.2 94.0 95.0 85. 7 93.0 90. 1
(0 sec) SD 5.3 5.5 2.4 6.4 6.4 8.4 4.5 7.6
10 sec M 100.0
101. OU 98.6a 94.3 96. 1 92.1 93.3 92.4
SD 4.3 3.8 2.9 6.4 3.3 6.3 4. 7 6. 7
20 sec M 100.2 105.0
b 99.0 97.9 98. 1 94.3 95.8 95.9
SD 3.3 4.4 1.9 4.8 2.3 6.9 4'7 8.0
40 sec M 99.8 101. 0 100.2 101.6 99. 1 101. 6
99.2 96.9
SD 1.4 2.0 5.1 9.5 3.3 5.2 4.5 8.2
60 sec M 102.0 103.0 99. 1 101. 2 98.9
101. 7 99.5 98.2
SD 2.2 2.3 5. 7 9.5 3.0 3.5 3. 7 7.5
LVET = left ventricular ejection time; SV = stroke volume; sBP = systolic blood pressure;
dBP = diastolic blood pressure. M=mean, SD = standard deviation.
Significant difference from control, a P<0.05, b P<O.Ol.
Data represented a percentage of hemodynamic measurement to each preocclusion value.
In the ischemic area prolonged occlusion of the LAD for 20 min markedly
lengthened points B, C and D during the initial five min. The changes in
segment-length did not differ substantially between two groups. The extent of
early systolic (point B) bulging was smaller in the propranolol group than in the
control at 10 and 20 min after occlusion (P<0.05), because point B in the control
group gradually lengthened during the 20 min following occlusion, whereas in
the propranolol group no further elongation was observed. Point D reached maxi-
mal lengthening during the first five min in both canine groups; no significant
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Fig. 3. Percent changes of stroke volume during and after release of brief coro-
nary occulusion (top), and that during coronary occlusion maintained for 20 min
(bottom).
Significant difference between the two groups: *P<O.Ol, +P<0.05.
TABLE 4. SEGMENT-LENGTH (MM) BEFORE AND AFTER OCCLUSION FOR 20 MIN
Pretreated with propranolol Control
Point A Point B Point C Point D Point A Point B Point C Point D
Before M 0 0.31 2. 78 2.90 0 -0.12 2.43 2.96
occlusion SD 0.23 0.51 0.38 0.45 0.62 0.44
5 min after M -0.39 -2.47 -1. 86 -0.98 -0.30 -3.87 -1. 83 -1.64
occlusion SD 0.27 0.96 0.41 O. 70 0.20 1. 26 0.48 0.40
10min after M -0.60 -2.75a -2.0l a -1. 28a -0.45 -4.51 -2.63 -1. 91
occlusion SD 0.20 1. 28 0.30 0.51 0.23 1. 25 0,46 0.59
20 min after M -0.64 -2. goa -1. 96 rt -1. 30 -0.53 -4.80 -2.61 -1. 92
occlusion SD 0.38 1. 29 0:44 0.49 0.21 1. 23 0.52 0.69
M=mean, SD = standard deviation.
Significant difference from the control, a P<0.05.
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Fig. 4. Dimensional changes in points of the segment-length curve in the ische-
mic zone during coronary occlusion maintained for 20 min.
Significant difference between the two groups: +P<0.05.
difference in the dimensions of point D was observed between the two groups.
A small increase in paradoxical lengthening in point C seen in the control group
from five to ten min after the occlusion was lost in the propranolol group (Table
4, Fig. 4).
In the normal area of the propranolol group, point B progressively length-
ened throughout the experiments. In contrast to this, point B in the control group
was rather increased in shortening following an initial slight reduction. Points
C and D in propranolol group decreased gradually in shortening, similar to those
in the control group. A significant difference in the dimension of point D, how-
ever, was observed between the two canine groups at 5, 10 and 20 min after the
occlusion (P<O.O1). Point C also showed significant differences in dimension
between the two groups at 5 and 20 min after the occlusion (Fig. 5).
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Fig. 5. Dimensional changes in poins of the segment-length curve in the normal
zone during coronary occlusion maintained for 20 min.
Significant difference between the two groups: **P<O.OOl, *P<O.Ol, +P<O. OS.
TABLE 5. PERCENT CHANGES OF HEMODYNAMIC MEASUREMENTS DURING
LAD OCCLUSION (%)
Pretrated with propranolol Control
LVET SV sBP dBP LVET SV sBP dBP
5 min M 97.3 88.0 95.0 90.6 102.5 81.° 93.0 93. 7SD 8.5 9.2 6.5 8.1 5.3 5.3 7.3 12.6
10 min M 100.6 88.4
a 96.9 94.4 102.0 80.4 93.9 94.6
SD 2.2 5.3 5.0 9.0 5.0 6.7 3.6 10.6
20 min M 99.9 89.0
a 94.1 94.0 101.6 80.9 91. 2 93.9
SD 3.6 6.9 5.6 7.6 5.9 5.5 5.5 7.0
LVET=left ventricular ejection time, SV=stroke volume, sBP=systolic blood pressure,
dBP=diastolic blood pressure. M=mean, SD=standard deviation.
Significant difference from control, a P<0.05.
Data represent the percentage ratio of each hemodynamic measurement to preocclusion
values.
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The occlusion of the LAD maintained for 20 min resulted in a fall in stroke
volume and blood pressure in both ~roups. The propranolol group showed a
lesser reduction of stroke volume which was significantly different at 10 and 20
min from that of the control group (P<0.05). This was in association with the
difference in the dimensions of points Band C of the two groups. Blood pressure
tended to fall less in the propranolol group than in the control group, though no
significant difference existed between the groups (Table 5).
DISCUSSION
Recently, attention has been focused on decreasing the degree of myocardial
injury (6-8). The fate of endangered ischemic tissue depends upon the balance
between oxygen requirement and supply. The ability of propranolol to decrease
the heart rate and myocardial contractility should favourably reduce myocardial
oxygen consumption. Furthermore possible redistribution of blood flow from
non-ischemic zones to the ischemic zone could be attributed to the improvement
of the impaired local myocardial function (9-11). Coronary occlusion produced
minor changes in systemic hemodynamics and function in normal myocardial
zones, but caused progressively greater impairment of function in the ischemic
segment. In the ischemic segment, paradoxical systolic lengthening was initiated
from the end-systolic point (point D) and extended rapidly to the early ejection
phase (point B). Primzmetal et al. (12) using high-speed cinematography, de-
scribed early systolic contraction with ballooning late in systole and sometimes
throughout systole. Hood et al. (13) also showed the segment lengthening nor-
mally observed during isovolumetric systole greatly increased during ischemia
and that shortening during the ejection phase disappeared. These are consistent
with the present findings, and the paradoxical systolic expansion resulted from
inability to sustain active tension development with increased myocardial com-
pliance in the ischemic segment (14). Propranolol pretreatment exerted apparent
effects on regional function in normal and ischemic segments. In the normal
segment, propranolol reduced the extent of shortening, minimally during and
after the brief coronary occlusion, but significantly during coronary occlusion
maintained for 20 min. In contrast, in the ischemic segment, propranolol sup-
pressed the extent of end-systolic abnormal contraction which was induced by one
min occlusion of the LAD and facilitated an improvement of paradoxical length-
ening during systole. Furthermore, the extent of passive stretching induced by
maintaining coronary occlusion fell significantly with propranolol pretreatment
in early systole. The depressant action of propranolol on systemic hemodynamics
and regional myocardial function in the normal zone was predictable, a finding
which is consistent with our previous report (15), and those of Mueller et ai. (16)
and Vatner et at. (17). The ability of propranolol to decrease the amount of ische-
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mia and necrosis after experimental coronary ligation was investigated recently
(18-20). The drug reduced the infarction size as estimated histologically (21).
The epicardial ECG mapping technique also confirmed the protective effects of
propranolol from ischemic injury (22, 23). Theroux et aI.. reported, using ultra-
sonic dimension gauges, a protecting effect of the drug, observing that the reduc-
tion in the extent of shortening was substantially less after propranolol adminis-
tration than it was during the control occlusion in both open-chest anesthetized
(24) and conscious (25) dogs. Vatner et al. (17) observed that in the ischemic
segment with paradoxical expansion during systole, propranolol decreased the
extent of paradoxical motion in contrary to the effect in the normal and moder-
ately ischemic segments in which the extent and velocity of shortening were
decreased by the drug. In the present study, in accord with these reports, favour-
able effects of propranolol were most evident in the dimension of early systole of
the ischemic segment at 10 and 20 min during the coronary occlusion. This
might suggest that propranolol had the favourable effect of maintaining develop-
ing tension during the isovolumetric contraction phase. One of the important
findings in this investigation was that propranolol accelerated the improvement
of the impaired segment-function after the release of a brief coronary occlusion.
An attack of angina pectoris with or without organic coronary lesions produced
severe myocardial ischemia that caused a transient paradoxical segmental expan-
sion in systole (26-28). Propranolol-accelerated restoration of segment function
might affect favourably left ventricular function in patients with angina pectoris
in addition to protecting patients from angina attack. Though the mechanisms
of the beneficial effects of propranolol pretreatment were not clear in the present
study, slowing heart rate might be the most important. A reduction of contrac-
tility and an increase in oxygen supply to the ischemic segment might play little
or no role in the beneficial effects, since the loss of contractile force in the severe
ischemic zone was almost complete (29) and propranolol had no ability to cause
redistribution of blood flow to ischemic areas in acutely induced myocardial
ischemia (30, 31). Of interest propranolol impeded normal segment in a com-
pensatory increase in shortening during the maintaining coronary occlusion.
This was most apparent in early systole when the drug significantly decreased the
extent of paradoxical systolic elongation in ischemic zone. Two possible mecha-
nisms of the effects, which would resulted in disturbing a compensatory increase
in shortening of normal segment, are the blocking effect of t-adrenergic receptor
of myocardium and a lessened effect of the Frank-Starling mechanism because of
a smaller residual volume in diastole.
Acknowledgment. The authors express their thanks to Prof. Hideo Nagashima of the
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